FIGS (NYSE:FIGS – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.01 EPS for the quarter, Briefing.com reports. The company had revenue of $144.23 million for the quarter, compared to analyst estimates of $142.25 million. FIGS had a net margin of 4.07% and a return on equity of 6.12%. The firm’s revenue was up 4.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.02 earnings per share. FIGS updated its FY 2024 guidance to EPS.
FIGS Stock Down 14.0 %
NYSE:FIGS traded down $0.80 during trading hours on Friday, reaching $4.92. 11,132,687 shares of the company’s stock were exchanged, compared to its average volume of 3,747,669. FIGS has a 1-year low of $4.30 and a 1-year high of $7.98. The firm has a market capitalization of $837.52 million, a price-to-earnings ratio of 44.73, a P/E/G ratio of 86.00 and a beta of 1.42. The company has a 50-day moving average of $5.57 and a 200 day moving average of $5.46.
Insider Buying and Selling at FIGS
In other FIGS news, insider Heather L. Hasson sold 40,149 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $5.70, for a total transaction of $228,849.30. Following the completion of the sale, the insider now directly owns 425,710 shares of the company’s stock, valued at approximately $2,426,547. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders have sold 44,638 shares of company stock worth $252,720. 22.30% of the stock is owned by company insiders.
Analysts Set New Price Targets
Read Our Latest Report on FIGS
About FIGS
FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.
Featured Stories
- Five stocks we like better than FIGS
- The Significance of Brokerage Rankings in Stock Selection
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 8/5 – 8/9
- Financial Services Stocks Investing
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.